NeuroPace (NPCE) Accumulated Depreciation & Amortization (2020 - 2026)
NeuroPace's quarterly Accumulated Depreciation & Amortization came in at $8.3 million in Q1 2026, up 3.11% year-on-year from $8.0 million in Q1 2025, and up 0.73% quarter-over-quarter from $8.2 million in Q4 2025.
NeuroPace has reported Accumulated Depreciation & Amortization for 7 years, with the latest figure at $8.3 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 3.11% year-over-year to $8.3 million; the trailing twelve-month figure through Mar 2026 stood at $8.3 million (up 3.11% YoY), and the FY2025 full-year result was $8.2 million, up 2.91% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at $8.3 million, up from $8.2 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $8.9 million in Q3 2023, with the low at $7.8 million in Q4 2023.
- Average Accumulated Depreciation & Amortization over 5 years is $8.3 million, with a median of $8.2 million recorded in 2025.
- Year-over-year, Accumulated Depreciation & Amortization rose 3.7% in 2022 and dropped 10.97% in 2023.
- Tracing NPCE's Accumulated Depreciation & Amortization over 5 years: stood at $8.7 million in 2022, then retreated by 10.97% to $7.8 million in 2023, then increased by 2.67% to $8.0 million in 2024, then advanced by 2.91% to $8.2 million in 2025, then rose by 0.73% to $8.3 million in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $8.3 million (Q1 2026), $8.2 million (Q4 2025), and $8.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.27 Mn |
| Mar 31, 2026 | 8.27 Mn |
| Dec 31, 2025 | 8.21 Mn |
| Dec 31, 2025 | 8.21 Mn |
| Sep 30, 2025 | 8.13 Mn |
| Sep 30, 2025 | 8.13 Mn |
| Jun 30, 2025 | 8.07 Mn |
| Jun 30, 2025 | 8.07 Mn |
| Mar 31, 2025 | 8.02 Mn |
| Mar 31, 2025 | 8.02 Mn |
| Dec 31, 2024 | 7.97 Mn |
| Dec 31, 2024 | 7.97 Mn |
| Sep 30, 2024 | 7.93 Mn |
| Sep 30, 2024 | 7.93 Mn |
| Jun 30, 2024 | 7.87 Mn |
| Jun 30, 2024 | 7.87 Mn |
| Mar 31, 2024 | 7.81 Mn |
| Mar 31, 2024 | 7.81 Mn |
| Dec 31, 2023 | 7.77 Mn |
| Dec 31, 2023 | 7.77 Mn |
| Sep 30, 2023 | 8.86 Mn |
| Sep 30, 2023 | 8.86 Mn |
| Jun 30, 2023 | 8.82 Mn |
| Jun 30, 2023 | 8.82 Mn |
| Mar 31, 2023 | 8.77 Mn |
| Mar 31, 2023 | 8.77 Mn |
| Dec 31, 2022 | 8.72 Mn |
| Dec 31, 2022 | 8.72 Mn |
| Sep 30, 2022 | 8.67 Mn |
| Sep 30, 2022 | 8.67 Mn |
| Jun 30, 2022 | 8.61 Mn |
| Jun 30, 2022 | 8.61 Mn |
| Mar 31, 2022 | 8.54 Mn |
| Mar 31, 2022 | 8.54 Mn |
| Dec 31, 2021 | 8.46 Mn |
| Dec 31, 2021 | 8.46 Mn |
| Sep 30, 2021 | 8.38 Mn |
| Sep 30, 2021 | 8.38 Mn |
| Jun 30, 2021 | 8.30 Mn |
| Jun 30, 2021 | 8.30 Mn |
| Mar 31, 2021 | 8.24 Mn |
| Mar 31, 2021 | 8.24 Mn |
| Dec 31, 2020 | 8.16 Mn |
| Dec 31, 2020 | 8.16 Mn |